Iterum TherapeuticsITRMF
13F holders, Q2 2025 (June 30)3holders +1
1new positions
0sold out
$0.99avg. 13F price*
At the end of Q2 2025, 3 institutions reported holding Iterum Therapeutics PLC (ITRMF) in their 13F filings, up 1 from Q1 2025. 1 opened new positions and 0 sold out. The largest holders were Creative Financial Designs Inc. ($76K), Captrust Financial Advisors ($11K) and Blue Bell Private Wealth Management, LLC ($66).
- Company
- Iterum Therapeutics PLC
- CUSIP
- G6333L101
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $11K |
| Exits | 0 | $0 |
All 13F filers, Q1 2025 → Q2 2025: 17,600 shares bought, net +17,600 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| Creative Financial Designs Inc. | 0.01% | Add +8.7% | 76,047 | $76K |
| Captrust Financial Advisors | 0.00% | New | 11,500 | $11K |
| Blue Bell Private Wealth Management, LLC | 0.00% | No change | 66 | $66 |
"% of holder's portfolio" is ITRMF's weight in each manager's 13F, not the share of Iterum Therapeutics PLC the manager owns.